20.6 C
New York
Wednesday, June 10, 2026

Tag: Africa

Active Optical Cable Market Fueled by AI Data-Center Traffic, Says Strategic Market Research

Global Active Optical Cable Market to grow from USD 3.6 billion in 2024 to USD 7.8 billion by 2030 as data centers, telecom operators,...

Active Optical Cable Market Fueled by AI Data-Center Traffic, Says Strategic Market Research

Global Active Optical Cable Market to grow from USD 3.6 billion in 2024 to USD 7.8 billion by 2030 as data centers, telecom operators,...

ReconAfrica has Commenced Production Testing at the Kavango West 1X Discovery

CALGARY, Alberta, June 08, 2026 (GLOBE NEWSWIRE) -- Reconnaissance Energy Africa Ltd. (the “Company” or “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC), along with partners NAMCOR and BW Energy, have commenced production testing operations at Kavango West 1X (“KW1X”).

Liquid-applied Membrane Market worth $35.47 billion by 2031 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 8, 2026 /PRNewswire/ -- According to MarketsandMarkets, "Liquid-applied Membrane Market by Type (Bituminous, Elastomeric, Cementitious), Application (Roofing, Walls, Roadways), Usage (New...

Liquid-applied Membrane Market worth $35.47 billion by 2031 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 8, 2026 /PRNewswire/ -- According to MarketsandMarkets, "Liquid-applied Membrane Market by Type (Bituminous, Elastomeric, Cementitious), Application (Roofing, Walls, Roadways), Usage (New...

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio® (vedolizumab) lyophilized vial for intravenous administration.

Expanding its partnership with non-profits, EZVIZ upgrades its Green Initiative to make a true impact on harmony between humans and nature with a week-long...

HOOFDDORP, Netherlands, June 8, 2026 /PRNewswire/ -- EZVIZ, a world-leading smart home brand, announced to enter a new chapter of its EZVIZ Green Initiative by expanding...

Canadian Employers Invited to Create 10,000 New Opportunities Through National Inclusive Hiring Campaign

Enabled Talent launches One Company. One Talent, inviting Canadian employers to create one inclusive opportunity and build a stronger workforce.

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance 

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAfrica